Arthneeti
Fundraise / allotmentFiled on BSE ·

Jubilant Pharmova Limited approves issuance of up to ₹800 crore NCDs on private placement

Jubilant Pharmova Ltd · Pharmaceuticals & Biotechnology

What the filing says

  • Board approved issuance of up to 80,000 secured/unsecured, listed, rated, redeemable NCDs of ₹1,00,000 each, aggregating up to ₹800 crore, in one or more tranches
  • NCDs issuance on private placement basis with tenure up to five years from deemed date of allotment
  • Members' approval to be sought by postal ballot for issuance of non-convertible debt securities up to ₹2,500 crore outstanding over one year from resolution date

Original filing

Board Meeting Outcome for Issuance Of Secured / Unsecured, Listed, Rated, Redeemable Non-Convertible Debentures (Ncds) On Private Placement Basis

Read the filing on BSE (PDF) →

Companies guiding to strong growth

Ranked by management's own guidance on revenue and margins — not by us.

Waaree Energies
Revenue growth 40%+Margin up 2%+

Sign up free to see all 6 →

See full rankings

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

More from Jubilant Pharmova Ltd

Other fundraise / allotment filings this fortnight

All fundraise / allotment filings →

Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.